GlaxoSmithKline | GSK

Stock Price
2,031.00
Daily Change
0 0%
Monthly
-7.01%
Yearly
32.23%
Q1 Forecast
1,988.76



Peers Price Chg Day Year Date
AbbVie 219.68 -5.69 -2.52% 3.74% Mar/13
Alcon AG 60.84 -0.76 -1.23% -22.24% Mar/13
Almirall 11.36 -0.20 -1.73% 10.18% Mar/13
Amgen 366.21 -1.58 -0.43% 16.74% Mar/13
argenx SE 613.80 -2.20 -0.36% 11.40% Mar/13
AstraZeneca 14,380.00 16.00 0.11% 20.80% Mar/14
Bayer 38.64 -0.50 -1.27% 62.40% Mar/14
Biogen 181.55 -3.35 -1.81% 30.20% Mar/13
Bristol-Myers Squibb 59.08 0.13 0.22% 0.12% Mar/13
Fresenius Medical Care 39.78 0.01 0.03% -9.73% Mar/14

Indexes Price Day Year Date
GB100 10261 -44.00 -0.43% 18.87% Mar/13
EU600 596 -3.01 -0.50% 9.01% Mar/13

GlaxoSmithKline traded at 2,031.00 this Saturday March 14th. Looking back, over the last four weeks, GlaxoSmithKline lost 7.01 percent. Over the last 12 months, its price rose by 32.23 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,988.76 by the end of this quarter and at 1,867.22 in one year, according to Trading Economics global macro models projections and analysts expectations.

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.



News Stream
GlaxoSmithKline Stock Price Hits 4-week Low
GlaxoSmithKline shares decreased to 2107.00 GBp, the lowest since February 2026. Over the past 4 weeks, GlaxoSmithKline lost 4%, and in the last 12 months, it increased 40.62%.
2026-03-05
GlaxoSmithKline Stock Price Hits 21-1/2-year High
GlaxoSmithKline shares increased to 2221.00 GBp, the highest since July 2004. Over the past 4 weeks, GlaxoSmithKline gained 21.97%, and in the last 12 months, it increased 53.5%.
2026-02-17
GlaxoSmithKline Stock Price Hits 21-1/2-year High
GlaxoSmithKline shares increased to 2062.00 GBp, the highest since July 2004. Over the past 4 weeks, GlaxoSmithKline gained 13.1%, and in the last 12 months, it increased 38.65%.
2026-02-04